Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 3/20 | 0.57 |
| ▸ | PPARA | Q07869 | 2/20 | 0.57 |
| ▸ | PPARD | Q03181 | 1/20 | 0.57 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.57 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.57 |
| ▸ | APP | P05067 | 4/20 | 0.52 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.51 |
| ▸ | MAOB | P27338 | 3/20 | 0.49 |
| ▸ | BACE1 | P56817 | 2/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.48 |
| ▸ | OSBP | P22059 | 1/20 | 0.46 |
| ▸ | PTGES | O14684 | 1/20 | 0.46 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2071527 | 0.80 | APP (0.51) | PPARGPPARAPPARDDNMT1SIRT5 | |
| SCHEMBL2071528 | 0.80 | APP (0.51) | PPARGPPARAPPARDDNMT1SIRT5 | |
| SCHEMBL6230271 | 0.80 | PPARG (0.59) | PPARGPPARAPPARDDNMT1SIRT5 | |
| SCHEMBL6230269 | 0.80 | PPARG (0.59) | PPARGPPARAPPARDDNMT1SIRT5 | |
| SCHEMBL25560799 | 0.78 | PPARG (0.78) | PPARGPPARAPPARDDNMT1SIRT5 | |
| SCHEMBL28699738 | 0.77 | MAOB (0.62) | PPARGPPARAPPARDDNMT1SIRT5 | |
| SCHEMBL25560675 | 0.76 | PPARG (0.78) | PPARGPPARAPPARDDNMT1SIRT5 | |
| SCHEMBL31312468 | 0.76 | APP (0.62) | PPARGPPARAAPPOPRD1MAOB | |
| SCHEMBL5820932 | 0.76 | APP (0.52) | PPARGPPARAPPARDDNMT1SIRT5 | |
| SCHEMBL12539779 | 0.74 | BACE1 (0.56) | APPMAOBBACE1PTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240101503-A1 | Process for the Production of Cannabinoids and Cannabinoid Acids | BESSOR PHARMA, LLC | 2024-03-28 | — | — | US | disclosed |
| EP-4041703-A1 | PROCESS FOR THE PRODUCTION OF CANNABINOIDS AND CANNABINOID ACIDS | Bessor Pharma, LLC (US) | 2022-08-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240101503-A1 | Process for the Production of Cannabinoids and Cannabinoid Acids | CNR2, CNR1, RARG | PPARG 374/4885PPARA 784/4885PPARD 1812/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.